Joshi Abhay 4
4 · Revance Therapeutics, Inc. · Filed Feb 4, 2021
Insider Transaction Report
Form 4
Joshi Abhay
Chief Operating Officer
Transactions
- Award
Common Stock
2021-02-02+22,620→ 134,570 total - Award
Employee Stock Option (Right to Buy)
2021-02-02+40,925→ 40,925 totalExercise: $28.01Exp: 2031-02-01→ Common Stock (40,925 underlying)
Footnotes (2)
- [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from March 15, 2021, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
- [F2]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from February 2,2021, subject to Dr. Joshi's Continuous Service (as defined in the Plan) on each vesting date.